Skip to main navigation Skip to search Skip to main content

Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland

  • Michael Brändle
  • , Katrina Erny-Albrecht
  • , Giatgen Spinas
  • , P. Streit
  • , William Valentine

    Research output: Contribution to journal › Article › peer-review

    21 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)501-515
    Number of pages15
    JournalInternational Journal of Clinical Pharmacology and Therapeutics
    Volume47
    Issue number8
    Publication statusPublished - 2009

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this